BioWorld

Feb. 3, 2004

BIO President Feldbaum To Retire; 'Timing Is Just Right'

WASHINGTON - Biotechnology Industry Organization President Carl Feldbaum on Monday said he'll retire and move to Idaho as soon as the group's executive committee hires his successor. (BioWorld Today) Read More

Targeted Genetics Adding $25.5M To Cash Via Public Stock Offering

Nastech Licenses RNAi Patents To Boost Tight Junctions Work

Icagen Brings In $19.5M For Clinical Programs, Research

Bush's 2005 Budget: More Funds For FDA, Vaccines

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for Jan 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 22, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...